Pfizer Personal Empowerment Portal
Patient-centered Tools for Education & Engagement

Pfizer is committed to helping people with chronic inflammatory diseases―atopic dermatitis (AD), psoriatic arthritis (PsA), rheumatoid arthritis (RA), and ulcerative colitis (UC)―become empowered to play an important role in managing their medical condition with their doctor.

The Personal Empowerment Portal offers a wide range of print and digital materials to support patients in this process.

Educational content on the Personal Empowerment Portal is designed to help patients partner with their medical team in shared decision-making about personal treatment-related issues and options. Materials are available in English and Spanish.

Patients and healthcare professionals (HCPs) will be able to access print and digital educational materials about AD, PsA, RA, and UC.

In summary, the Personal Empowerment Portal delivers resources for patients to support shared decision-making and communication with their physician.

image of patient
Atopic Dermatitis
  • In-depth clinical information to help patients better understand AD, including its signs, symptoms, and some medications that may be used to treat it1
  • Self-assessment tools, application instructions, and action plan forms to help patients identify ways to work with their HCPs in managing their AD
Learn more
image of patient
Psoriatic Arthritis
  • Clinical information about common signs and symptoms, the effects on different areas of the body, and the potential risks of developing other conditions when you have PsA
  • Insights on the principal goals of PsA treatment―along with questionnaires and information-gathering tools―to help patients work with rheumatologists, dermatologists, and other HCPs to support treatment
Learn more
image of patient
Rheumatoid Arthritis
  • Useful clinical insights about RA, including its signs, symptoms, and some medications that may be used to treat it2
  • Questionnaires and self-assessment tools to evaluate treatment progress and identify ways to work with HCPs in managing RA through the Treat-to-Target (T2T) approach to individualized patient care
Learn more
image of patient
Ulcerative Colitis
  • Clinical information about UC, including its signs, symptoms, and some medications that may be used to treat it3
  • Diaries, questionnaires, and self-assessment tools that monitor UC-related symptoms―including stool frequency and rectal bleeding―as well as other potential signs and symptoms, such as fatigue and lifestyle challenges
Learn more
References
  1. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116-132.
  2. National Institutes of Health. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Handout on Health: Rheumatoid Arthritis. NIH Publication No. 17-4179. April 2017.
  3. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017;389(10080):1756-1770.